System theory of pain and of opiate analgesia: No tolerance to opiates

Pharmacological Reviews

Volumn 48, Issue 3, 1996, Pages 355-402

  Colpaert, Francis C ^a  

^a INSTITUT DE RECHERCHE PIERRE FABRE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

3,4 DICHLORO N METHYL N [2 (1 PYRROLIDINYL)CYCLOHEXYL]BENZENEACETAMIDE METHANESULFONATE; ACETORPHAN; BUPRENORPHINE; ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; ENKEPHALINASE INHIBITOR; FENTANYL; KELATORPHAN; LEUCINE ENKEPHALIN[2 DEXTRO SERINE 6 THREONINE]; MORPHINE; OPIATE; OPIATE AGONIST; OPIATE RECEPTOR; PETHIDINE; SUBSTANCE P RECEPTOR; SUFENTANIL; TACHYKININ RECEPTOR AGONIST;

ADJUVANT DISEASE; ANALGESIA; ANALGESIC ACTIVITY; CANCER PAIN; CHRONIC PAIN; DISCRIMINATIVE STIMULUS; DRUG DISCRIMINATION; DRUG THERAPY; DRUG TOLERANCE; EPIDURAL DRUG ADMINISTRATION; ETIOLOGY; HUMAN; HYPERALGESIA; HYPOALGESIA; INTRAPERITONEAL DRUG ADMINISTRATION; MATHEMATICAL MODEL; NOCICEPTIVE STIMULATION; NONHUMAN; OPIATE ADDICTION; PAIN; PRIORITY JOURNAL; REVIEW; SUBCUTANEOUS DRUG ADMINISTRATION;

ANALGESICS, OPIOID; ANIMALS; DRUG TOLERANCE; HUMANS; PAIN;

EID: 0029833205     PISSN: 00316997     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (441)

1. ABBADIE, C., AND BESSON, J.-M.: C-fos expression in rat lumbar spinal cord during the development of adjuvant-induced arthritis. Neuroscience 48: 985-993, 1992.
2. ABBADIE, C., AND BESSON, J.-M.: Effects of morphine and naloxone on basal and evoked Fos-like immunoreactivity in lumbar spinal cord neurons of arthritic rats. Pain 52: 29-39, 1993.
3. ABBADIE, C., BESSON, J.-M., AND CALVINO, B.: C-fos expression in the spinal cord and pain-related symptoms induced by chronic arthritis in the rat are prevented by pretreatment with Freund adjuvant. J. Neurosci. 14: 5865-5871, 1994.
4. ABBOTT, F. V., FRANKLIN, K. B. J., LUDWICK, R. J., AND MELZACK, R.: Apparent lack of tolerance in the formalin test suggests different mechanisms for morphine analgesia in different types of pain. Pharmacol. Biochem. Behav. 15: 637-640, 1981.
5. ABBOTT, F. V., MELZACK, R., AND LEBER, B. F.: Morphine analgesia and tolerance in the tail-flick and formalin tests: dose-response relationships. Pharmacol. Biochem. Behav. 17: 1213-1219, 1982.
6. ADLER, M. W.: Mechanisms of opioid tolerance and dependence: symposium summary. In Problems of Drug Dependence, Proceedings of the 48th Annual Scientific Meeting, ed. by L. S. Harris, The Committee on Problems of Drug Dependence, Inc., NIDA Res. Monogr., US Government Printing Office, Washington, DC, vol. 76, pp. 63-68, 1987.
7. AGHAJANIAN, G. K., AND WANG, Y. Y.: Pertussis toxin blocks the outward currents evoked by opiate and alpha two agonists in locus coeruleus neurons. Brain Res. 371: 390-394, 1986.
8. ALARCON, G., AND CERVERO, F.: The effects of electrical stimulation of A and C visceral afferent fibres on the excitability of viscerosomatic neurones in the thoracic spinal cord of the cat. Brain Res. 509: 24-30, 1990.
9. 1 receptors and stimulatory G proteins. Brain Res. 707: 235-244, 1996.
10. ANDREWS, H. L.: The effect of opiates on the pain threshold in post-addicts. J. Clin. Invest. 22: 511-516, 1943.
11. ANDREWS, H. L., AND HIMMELSBACH, C. K.: Relation of the intensity of the morphine abstinence syndrome to dosage. J. Pharmacol. Exp. Ther. 81: 288-293, 1944.
12. ARIËNS, E. J.: The mode of action of biologically active compounds. In Molecular Pharmacology, vol. 1, Academic Press, New York, 1964.
13. ARNER, S., AND ARNER, B.: Differential effects of epidural morphine in the treatment of cancer-related pain. Acta Anaesthesiol. Scand. 29: 32-36, 1985.
14. ARNER, S., RAWAL, N., AND GUSTAFSSON, L. L.: Clinical experience of long-term treatment with epidural and intrathecal opioids: a nationwide survey. Acta Anaesthesiol. Scand. 32: 253-259, 1988.
15. AWOUTERS, F., NIEMEGEERS, C. J. E., LENAERTS, F. M., AND JANSSEN, P. A. J.: The effects of suprofen in rats with Mycobacterium butyricum-induced arthritis. Arzneim. Forsch. 25: 1526-1537, 1975.
16. BABBINI, M., AND DAVIS, W. M.: Time dose relationship for locomotor activity effects of morphine after acute or repeated treatment. Br. J. Pharmacol. 46: 213-224, 1972.
17. BALDESSARINI, R. J.: Drugs and the treatment of psychiatric disorders. In Goodman and Gilman's The Pharmacological Basis of Therapeutics, ed. by A. Goodman Gilman, T. W. Rall, A. S. Nies, and P. Taylor, 3rd ed., pp. 383-435, Pergamon Press, New York, 1990.
18. BASBAUM, A. I., AND FIELDS, H. L.: Endogenous pain control systems: brain-stem spinal pathways and endorphin circuitry. Annu. Rev. Neurosci. 7: 309-338, 1984.
19. BASBAUM, A. I., MENÉTREY, D., PRESLEY, R. W., AND LEVINE, J. D.: The contribution of the nervous system to experimental arthritis in the rat. In The Arthritic Rat as a Model of Clinical Pain, ed. by J.-M. Besson and G. Guilbaud, pp. 41-54, Elsevier, Amsterdam, 1988.
20. BEECHER, H. K.: The measurement of pain. Pharmacol. Rev. 9: 59-209, 1957.
21. BEECHER, H. K.: Measurement of Subjective Responses: Quantitative Effects of Drugs. Oxford University Press, New York, 1959.
22. BEITNER, D. B., DUMAN, R. S., AND NESTLER, E. J.: A novel action of morphine in the rat locus coeruleus: persistent decrease in adenylate cyclase. Mol. Pharmacol. 35: 559-564, 1989.
23. BELLEVILLE, R. E.: Control of behavior by drug-produced internal stimuli. Psychopharmacologia 5: 95-105, 1964.
24. BELVEDERE, G., AND DOLFINI, E.: Studies on low-level MDR cells. Cytotechnology 12: 257-264, 1993.
25. BERVOETS, K., AND COLPAERT, F. C.: Respiratory effects of intrathecal capsaicin in arthritic and non-arthritic rats. Life Sci. 34: 2477-2483, 1984.
26. BESSON, J.-M., AND CHAOUCH, A.: Peripheral and spinal mechanisms of nociception. Physiol. Rev. 67: 67-186, 1987.
27. BESSON, J.-M., DICKINSON, A. H., LE BARS, D., AND OLIVERAS, J.-L.: Opiate analgesia: the physiology and pharmacology of spinal pain systems. In Neuropsychopharmacology, Proceedings of the 7th International Congress of Pharmacology, ed. by J.-M. Besson and A. H. Dickinson, pp. 61-81, Pergamon Press: Oxford, 1978.
28. BHARGAVA, H. A., MATWYSHYN, G. A., GERK, P. M., BOZEK, P. S., BAILEY, M. D., KO, K. H., SIMKO, R. J., AND THORAT, S. N.: Effects of naltrexone pellet implantation on morphine tolerance and physical dependence in the rat. Gen. Pharmacol. 25: 149-155, 1994.
29. BICKEL, W. K., STITZER, M. L., LIEBSON, I. A., AND BIGELOW, G. D.: Acute physical dependence in man: effects of naloxone after brief morphine exposure. J. Pharmacol. Exp. Ther. 244: 126-132, 1988.
30. BLÄSIG, J., HERZ, A., REINHOLD, K., AND ZIEGLGANSBERGER, S.: Development of physical dependence on morphine in respect to time and dosage and quantification of the precipitated withdrawal syndrome in rats. Psychopharmacology 33: 19-38, 1973.
31. BORGBJERG, F. M., NIELSEN, K., AND FRANKS, J.: Experimental pain stimulates respiration and attenuates morphine-induced respiratory depression: a controlled study in human volunteers. Pain 64: 123-128, 1996.
32. BOUHASSIRA, D., GALL, O., CHITOUR, D., AND LE BARS, D.: Dorsal horn convergent neurones: negative feedback triggered by spatial summation of nociceptive afferents. Pain 62: 195-200, 1995.
33. BOUHASSIRA, D., LE BARS, D., AND VILLANUEVA, L.: Heterotopic activation of Aδ- and C-fibres triggers inhibition of trigeminal and spinal convergent neurones in the rat. J. Physiol. (Lond.) 389: 301-317, 1987.
34. BRONSTEIN, J. M., FARBER, D. B., AND WASTERLAIN, C. G.: Regulation of type-II calmodulin kinase: functional implications. Brain Res. Rev. 18: 135-147, 1993.
35. BRUERA, E., MACMILLAN, D., HANSON, J., AND MACDONALD, R. N.: The Edmonton staging system for cancer pain: preliminary report. Pain 37: 203-210, 1989.
36. BRUERA, E., MACMILLAN, K., KUEHN, N., AND MILLER, M. J.: Circadian distribution of extra doses of narcotic analgesics in patients with cancer pain: a preliminary report. Pain 49: 311-314, 1992.
37. BUCKLEY, P. F.: Somatic nerve block for post operative analgesia. In Acute Pain, ed. by G. Smith and B. G. Covino, pp. 205-227, Butterworth & Co., London, 1985.
38. BUCSICS, A., AND LEMBECK, F.: In vitro release of substance P from spinal cord slices by capsaicin congeners. Eur. J. Pharmacol. 71: 71-77, 1981.
39. BUDAI, D., AND LARSON, A. A.: Role of substance P in the modulation of C-fiber-evoked responses of spinal dorsal horn neurones. Brain Res. 710: 197-203, 1996.
40. BURITOVA, J., HONORÉ, P., CHAPMAN, V., AND BESSON, J.-M.: Concurrent reduction of inflammation and spinal Fos-LI neurons by systemic diclofenac in the rat. Neurosci. Lett. 188: 175-178, 1995.
41. BUTLER, S. H., WEIL-FUGAZZA, J., GODEFROY, F., AND BESSON, J.-M.: Reduction of arthritis and pain behaviour following chronic administration of amitryptiline or imipramine in rats with adjuvant-induced arthritis. Pain 23: 159-175, 1985.
42. BYARD, R. W.: Possible mechanisms responsible for the sudden infant death syndrome. J. Paediatr. Child Health 27: 147-157, 1991.
43. CALABRO-JONES, P. M., BYFIELD, J. E., WARD, J. F., AND SHARP, T. R.: Time dose relationship for 5-fluorouracil toxicity against human epithelial cancer cells in vivo. Cancer Res. 42: 4413-4419, 1982.
44. CALVINO, B., COURAND, J. Y., AND BESSON, J.-M.: Prevaccination with diluted Freund adjuvant prevents the development of chronic pain and transient release of cerebrospinal fluid substance P in adjuvant-induced arthritis in rats. Pain 58: 211-217, 1994.
45. CALVINO, B., CREPON-BERNARD, M.-O., AND LE BARS, D.: Parallel clinical and behavioural studies of adjuvant-induced arthritis in the rat: possible relationship with "chronic pain." Behav. Brain Res. 24: 11-29, 1987a.
46. CALVINO, B., VILLANUEVA, L., AND LEBARS, D.: Dorsal horn (convergent) neurones in the intact anesthetized arthritic rat: I. segmental excitatory influences. Pain 28: 81-98, 1987b.
47. CANNON, W. B.: Bodily Changes in Pain, Hunger, Fear and Rage, 2nd ed. Appleton, New York, 1929.
48. CAPETOLA, R. J., SHRIVER, D. A., AND ROSENTHALE, M. E.: Suprofen, a new peripheral analgesic. J. Pharmacol. Exp. Ther. 214: 16-23, 1980.
49. CAPPELL, H., LE BLANC, A. E., AND ENDRENYI, L.: Aversive conditioning by psychoactive drugs: effects of morphine, alcohol and chlordiazepoxide. Psychopharmacology 29: 239-246, 1973.
50. CAPUTI, C. A., BUSCA, G., FOGLIARDI, A., AND GIUGLIANO, F.: Evaluation of tolerance in long-term treatment of cancer pain with epidural morphine. Int. J. Clin. Pharmacol. Ther. Toxicol. 21: 587-590, 1983.
51. CARMON, A., MOR, J., AND GOLDBERG, J.: Application of laser to psychophysiological study of pain in man. In Advances in Pain Research and Therapy, ed. by J. J. Bonica and D. Albe-Fessard, vol. 1, pp. 375-380, Raven Press, New York, 1976.
52. CESSELIN, F., BOURGOIN, S., ARTAUD, F., AND HAMON, L.: Basic and regulatory mechanisms of in vitro release of met-enkephalin form the dorsal zone of the rat spinal cord. J. Neurochem. 43: 763-773, 1984.
53. CESSELIN, F., MONTASTRUC, J. L., GROS, C., BOURGOIN, S., AND HAMON, M.: Met-enkephalin levels and opiate receptors in the spinal cord of chronic suffering rats. Brain Res. 191: 289-293, 1980.
54. CHAPMAN, C. R., CASEY, K. L., DUBNER, R., FOLEY, K. M., GRACELY, R. H., AND READING, A. E.: Pain measurement: an overview. Pain 22: 1-31, 1985.
55. CHENEY, D. L., AND GOLDSTEIN, A.: Tolerance to opioid narcotics: time and reversibility of physical dependence in mice. Nature (Lond.) 232: 477-478, 1971.
56. CHERNICK, V.: Fetal breathing movements and the onset of breathing at birth. Clin. Perinatol. 5: 257-268, 1978.
57. CHERY-CROZE, S., KOCHER, L., BERNARD, C., AND CHAYVIALLE, J. A.: Substance P-, somatostatin-, vasoactive intestinal peptide- and cholecystokinine-like levels in the spinal cord of polyarthritic rats. Brain Res. 339: 183-185, 1985.
58. CLARK, W. C., AND YANG, J. C.: Application of sensory decision theory to problems in laboratory and clinical pain. In Pain Measurement and Assessment, ed. by R. Melzack, pp. 3-25, Raven Press, New York, 1983.
59. CLOUET, D. H., AND IWATSUBO, K.: Mechanisms of tolerance to and dependence on narcotic analgesic drugs. Annu. Rev. Pharmacol. 15: 49-71, 1975.
60. CLUTTON-BROCK, J.: The cerebral effects of overventilation. Br. J. Anaesth. 29: 111-113, 1957.
61. CLYNES, M., ED.: Multiple Drug Resistance in Cancer: Cellular, Molecular and Clinical Approaches. Kluwer Academic Publishers, Dordrecht, The Netherlands, 1994.
62. COCHIN, J., AND KORNETSKY, C.: Development and loss of tolerance to morphine in the rat after single and multiple injections. J. Pharmacol. Exp. Ther. 145: 1-10, 1964.
63. COGGESHALL, R. E., HONG, K. A. P., LANGFORD, L. A., SCHAIBLE, H. G., AND SCHMIDT, R. F.: Discharge characteristics of fine medial articular afferents at rest, during passive movements of inflamed knee joints. Brain Res. 272: 185-188, 1983.
64. COHEN, P.: Signal integration at the level of protein kinases, protein phosphatases and their substrates. Trends Biochem. Sci. 17: 408-413, 1992.
65. COLLIER, H. O. J.: Cellular site of opiate dependence. Nature (Lond.) 283: 625-629, 1980.
66. COLLIER, H. O. J., AND ROY, A. C.: Morphine like drugs inhibit the stimulation by E prostaglandins of cyclic AMP formation by rat brain homogenate. Nature (Lond.) 248: 24-27, 1974.
67. COLLIN, E., POULAIN, P., GAUVAIN-PIQUARD, A., PETIT, G., AND PICHARD-LEANDRI, E.: Is disease progression the major factor in morphine "tolerance" in cancer pain treatment? Pain 55: 319-326, 1993.
68. COLLIN, E., AND CESSELIN, F.: Neurobiological mechanisms of opioid tolerance and dependence. Clin. Neuropharmacol. 14: 465-488, 1991.
69. COLPAERT, F. C.: Narcotic cue and narcotic state. Life Sci. 20: 1097-1108, 1977.
70. COLPAERT, F. C.: Discriminative stimulus properties of narcotic analgesic drugs. Pharmacol. Biochem. Behav. 9: 863-887, 1978a.
71. COLPAERT, F. C.: Narcotic cue, narcotic analgesia, and the tolerance problem: the regulation of sensitivity to drug cues and to pain by an internal cue processing model. In Stimulus Properties of Drugs: Ten Years of Progress, ed. by F. L. Colpaert and J. Rosecrans, pp. 301-321, Elsevier Biomedical Press, Amsterdam, 1978b.
72. COLPAERT, F. C.: Long term suppression of pain by narcotic drugs in the absence of tolerance development. Arch. Int. Pharmacodyn. Ther. 236: 293-295, 1978c.
73. COLPAERT, F. C.: Can chronic pain be suppressed despite purported tolerance to narcotic analgesia. Life Sci. 24: 1201-1210, 1979.
74. COLPAERT, F. C.: The pharmacological specificity of opiate drug discrimination. In Drug Discrimination: Applications in CNS Pharmacology, ed. by F. L. Colpaert and J. Slangen, pp. 3-16, Elsevier Biomedical Press, Amsterdam, 1982.
75. COLPAERT, F. C.: Evidence that adjuvant arthritis in the rat is associated with chronic pain. Pain 28: 201-202, 1987.
76. COLPAERT, F. C.: A mnesic trace locked into the benzodiazepine state of memory. Psychopharmacology 102: 28-36, 1990.
77. COLPAERT, F. C.: Drug discrimination: no evidence for tolerance to opiates. Pharmacol. Rev. 47: 605-629, 1995.
78. COLPAERT, F. C., BERVOETS, K. J. W., AND VAN DEN HOOGEN, R. H. W. M.: Pharmacological analysis of hyperventilation in arthritic rats. Pain 33: 243-258, 1987.
79. COLPAERT, F. C., DE WITTE, P., MAROLI, A. N., AWOUTERS, F., NIEMEGEERS, C. J. E., AND JANSSEN, P. A. J.: Self administration of the analgesic suprofen in arthritic rats: evidence of mycobacterium butyricum-induced arthritis as an experimental model of chronic pain. Life Sci. 27: 921-928, 1980b.
80. COLPAERT, F. C., DONNERER, J., AND LEMBECK, P.: Effects of capsaicin on inflammation and on the substance P content of nervous tissues in rats with adjuvant arthritis. Life Sci. 32: 1827-1834, 1983.
81. COLPAERT, F. C., AND JANSSEN, P. A. J.: Agonist and antagonist effects of prototype opiate drugs in rats discrimination fentanyl from saline: characteristics of partial generalization. J. Pharmacol. Exp. Ther. 230: 193-199, 1984.
82. COLPAERT, F. C., AND JANSSEN, P. A. J.: Agonist and antagonist effects of prototype opiate drugs in fentanyl dose-dose discrimination. Psychopharmacology 90: 222-228, 1986.
83. COLPAERT, F. C., KUYPS, J. J. M. D., NIEMEGEERS, C. J. E., AND JANSSEN, P. A. J.: Discriminative stimulus properties of fentanyl and morphine: tolerance and dependence. Pharmacol. Biochem. Behav. 5: 401-408, 1976b.
84. COLPAERT, F. C., MEERT, T. H., DE WITTE, P. H., AND SCHMITT, P.: Further evidence validating adjuvant arthritis as an experimental model of chronic pain in the rat. Life Sci. 31: 67-75, 1982.
85. COLPAERT, F. C., NIEMEGEERS, C. J. E., AND JANSSEN, P. A. J.: The narcotic discriminative stimulus complex: relation to analgesic activity. J. Pharm. Pharmacol. 28: 183-187, 1976c.
86. COLPAERT, F. C., NIEMEGEERS, C. J. E., AND JANSSEN, P. A. J.: Theoretical and methodological considerations on drug discrimination learning. Psychopharmacologia 46: 169-177, 1976a.
87. COLPAERT, F. C., NIEMEGEERS, C. J. E., AND JANSSEN, P. A. J.: On the ability of narcotic antagonists to produce the narcotic cue. J. Pharmacol. Exp. Ther. 197: 180-187, 1976d.
88. COLPAERT, F. C., NIEMEGEERS, C. J. E., AND JANSSEN, P. A. J.: Studies on the regulation of sensitivity to the narcotic cue. Neuropharmacology 17: 705-713, 1978a.
89. COLPAERT, F. C., NIEMEGEERS, C. J. E., AND JANSSEN, P. A. J.: Narcotic cuing and analgesic activity of narcotic analgesics: associative and dissociative characteristics. Psychopharmacology 57: 21-26, 1978b.
90. COLPAERT, F. C., NIEMEGEERS, C. J. E., AND JANSSEN, P. A. J.: Nociceptive stimulation prevents development of tolerance to narcotic analgesia. Eur. J. Pharmacol. 49: 335-336, 1978c.
91. COLPAERT, F. C., NIEMEGEERS, C. J. E., JANSSEN, P. A. J., AND MAROLI, A. N.: The effects of prior fentanyl administration and of pain on fentanyl analgesia: tolerance to and enhancement of narcotic analgesia. J. Pharmacol. Exp. Ther. 213: 418-424, 1980a.
92. COLPAERT, F. C., AND SHEARMAN, G. T.: Tolerance, endorphins and other aspects of opiate drug discrimination. In Endorphins, Opiates and Behavioural Processes, ed. by R. L. Rodgers and S. J. Cooper, pp. 77-105, J. Wiley and Sons, Ltd., London, 1988.
93. COLPAERT, F. C., AND SLANGEN, J., EDS.: Drug Discrimination: Applications in CNS Pharmacology. Elsevier Biomedical Press, Amsterdam, 1982.
94. COLPAERT, F. C., AND VAN DEN HOOGEN, E. H. W. M.: Ventilatory response to adjuvant arthritis in the rat. Life Sci. 32: 957-963, 1983a.
95. COLPAERT, F. C., AND VAN DEN HOOGEN, R. H. W. M.: Time course of the ventilatory response to adjuvant arthritis in the rat. Life Sci. 33: 1065-1073, 1983b.
96. COMROE, J. H., FORSTER, R. E., DUBOIS, A. B., BRISCOE, W. A., AND CARLSEN, E.: The Lung, 2nd ed. Year Book Medical Publishers, Chicago, 1962.
97. COSTA, T., AND HERZ, A.: Antagonists with negative intrinsic activity at S opioid receptors coupled to GTP-binding proteins. Proc. Natl. Acad. Sci. USA 86: 7321-7325, 1989.
98. COSTA, T., OGINO, Y., MUNSON, P. J., ONORAN, H. O., AND RODBARD, D.: Drug efficacy at guanine nucleotide-binding regulatory protein-linked receptors: thermodynamic interpretation of negative antagonism and of receptor activity in the absence of ligand. Mol. Pharmacol. 41: 549-560, 1990.
99. COX, B. M.: Drug tolerance and physical dependence. In Principles of Drug Action. The Basis of Pharmacology, ed. by W. L. Pratt and P. Taylor, pp. 639-690, Churchill Livingstone, New York, 1990.
100. COX, B. M., GINSBURG, M., AND OSMAN, O. H.: Acute tolerance to narcotic analgesic drugs in rats. Br. J. Pharmac. Chemother. 33: 245-256, 1968.
101. COX, B. M., AND WERLING, L. L.: Opioid tolerance and dependence. In The Biological Bases of Drug Tolerance and Dependence, ed. by J. A. Pratt, pp. 199-229, Academic Press, New York, 1991.
102. CRUWYS, S. C., GARRETT, N. E., AND KIDD, B. L.: Sensory denervation with capsaicin attenuates inflammation and nociception in arthritic rats. Neurosci. Lett. 193: 205-207, 1995.
103. DAHLLOF, B., MARTINSSON, T., AND LEVAN, G.: Resistance to actinomycin D and to vincristine induced in a SEWA mouse tumor cell line with concomitant appearance of double minutes and a low-molecular-weight protein. Exp. Cell Res. 152: 415-426, 1984.
104. DARDICK, S. J., BASBAUM, A. I., AND LEVINE, J. D.: The contribution of pain to disability in experimentally induced arthritis. Arthritis Rheum 29: 1017-1022, 1986.
105. DE CASTRO-COSTA, M., DE SUTTER, P., GYBELS, J., AND VAN HEES, J.: Adjuvant induced arthritis in rats: a possible animal model of chronic pain. Pain 10: 173-185, 1981.
106. DE CASTRO-COSTA, M., GYBELS, J., KUPERS, R., AND VAN HEES, J.: Scratching behaviour in arthritic rats: a sign of chronic pain or itch? Pain 29: 123-131, 1987.
107. DE LEON-CASASOLA, O. A., AND LEMA, M. J.: Epidural bupivacaine/sufentanil therapy for postoperative pain control in patients tolerant to opioid and unresponsive to epidural bupivacaine/morphine. Anesthesiobgy 80: 303-309, 1994.
108. DENEAU, G. A., AND SEEVERS, M. H.: Pharmacological aspects of drug dependence. Adv. Pharmacol. Chemother. 3: 267-283, 1964.
109. DENNIS, S. G., AND MELZACK, R.: Comparison of phasic and tonic pain in animals. Adv. Pain Res. Ther. 3: 747-760, 1979.
110. DESMOND, M. M., AND WILSON, G. S.: Neonatal Abstinence Syndrome: recognition and diagnosis. Addict. Dis. 2: 113-121, 1975.
111. DICKINSON, A. H.: Mechanisms of the analgesic action of opiates and opioids. Br. Med. Bull. 47: 690-702, 1991.
112. DICKINSON, A. H., AND LE BARS, D.: Diffuse noxious inhibitory controls (DNIC) involve trigeminothalamic and spinothalamic neurones in the rat. Exp. Brain Res. 49: 174-180, 1983.
113. DING, Y.-Q., NOMURA, S., KANETO, T., AND MIZUNO, N.: Co-localization of μ-opioid receptor-like and substance P-like immunoreactivities in axon terminals within the superficial layers of the medullary and spinal dorsal horns of the rat. Neurosci. Lett. 198: 45-48, 1995.
114. DRIESSEN, J. J., DE MULDER, P. H. M., CLAESSEN, J. J. L., VAN DIEJEN, D., AND WOBBES, T.: Epidural administration of morphine for control of cancer pain: long-term efficacy and complications. Clin. J. Pain 5: 217-222, 1989.
115. DRORBAUGH, J. E., AND FENN, W. O.: A barometric method for measuring ventilation in newborn infants. Pediatrics 16: 81-87, 1955.
116. DUBNER, R.: Editorial comment. Pain 47: 1-2, 1991.
117. DUBUISSON, D., AND DENNIS, S. G.: The formalin test: a quantitative study of the analgesic effects of morphine, meperidine, and brain stem stimulation in rats and cats. Pain 4: 161-174, 1977.
118. DUGGAN, A. W., HALL, J. G., AND HEADLEY, P. M.: Enkephalins and dorsal horn neurones of the cat: effects on responses to noxious and innocuous skin stimuli. Br. J. Pharmacol. 61: 399-408, 1977.
119. DUGGAN, A. W., AND NORTH, R. A.: Electrophysiology of opioids. Pharmacol. Rev. 35: 219-281, 1984.
120. DUMAN, R. S., TALLMAN, J. F., AND NESTLER, E. J.: Acute and chronic opiate-regulation of adenylate cyclase in brain: specific effects in locus coeruleus. J. Pharmacol. Exp. Ther. 246: 1033-1039, 1988.
121. DUTTAROY, A., AND YOBURN, B. C.: The effect of intrinsic efficacy on opioid tolerance. Anesthesiology 82: 1226-1236, 1995.
122. EDDY, N. B., HALBACH, H., AND BRAENDON, O. J.: Synthetic substances with morphine-like effect. Bull. W. H. O. 17: 569-863, 1957.
123. EGER, E. I., DOLAN, W. M., STEVENS, W. C., MILLER, R. D., AND WAY, W. L.: Surgical stimulation antagonizes the respiratory depression produced by forane. Anesthesiology 36: 544-549, 1972.
124. ESPOSITO, R. V., AND KORNETSKY, C.: Opioids and rewarding brain stimulation. Neurosci. Biobehav. Rev. 2: 115-122, 1978.
125. FACCINI, E., UZUMAKI, M., GOVONI, S., MISSALE, C., SPANO, P. F., COVELLI, V., AND TRABUCCHI, M.: Afferent fibres mediate the increase of met-enkephalin elicited in rat spinal cord by localized pain. Pain 18: 25-31, 1984.
126. FERNANDES, M., KLUWE, S., AND COPER, H.: Development of tolerance to morphine in the rat. Psychopharmacology 54: 197-201, 1977a.
127. FERNANDES, M., KLUWE, S., AND COPER, H.: Quantitative assessment of tolerance to and dependence on morphine in mice. Naunyn-Schmiedebergs Arch. Pharmakol. 297: 53-60, 1977b.
128. FIELDS, H. L., AND BASBAUM, A. I.: Central nervous system mechanisms of pain modulation. In Textbook of Pain, ed. by P. L. Wall and R. Melzack, pp. 243-257, Churchill Livingstone, Edinburgh, 1994.
129. FIELDS, H. L., COX, B. M., FOLEY, K. M., HAASE, A. F., HERZ, A., HUMMEL, T., IADORALA, M. J., JAGE, J., LADURON, P., STEIN, C., STEWART, J., VAUGHT, J. L., AND YAKSH, T. L.: Strategies for improving the pharmacological approaches to the maintenance of analgesia in chronic pain. In Towards a New Pharmacotherapy of Pain, ed. by A. L. Basbaum and J.-M. Besson, pp. 205-226, John Wiley & Sons, Ltd., New York, 1991.
130. FITZGERALD, M.: c-Fos and the changing face of pain. Trends Neurosci. 13: 439-440, 1990.
131. FITZGIBBON, D. R., AND GALER, B. S.: The efficacy of opioids in cancer pain syndromes. Pain 58: 429-431, 1994.
132. FLECKNELL, P. A., KIRK, A. J. B., LILES, J. H., HAYES, P. H., AND DARK, J. H.: Post-operative analgesia following thoracotomy in the dog: an evaluation of the effects of bupivacaine intercostal nerve block and nalbuphine on respiratory function. Lab. Anim. 25: 319-324, 1991.
133. FLEISCHMANN, A., AND URCA, G.: Clip induced analgesia: noxious neck pinch suppresses spinal and mesencephalic neural responses to noxious peripheral stimulation. Physiol. Behav. 46: 151-157, 1989.
134. FOLEY, K. M.: Controversies in cancer pain: medical perspectives. Cancer 63: 2257-2265, 1989.
135. FOLEY, K. M.: Clinical tolerance to opioids. In Towards a New Pharmacotherapy of Pain, ed. by A. I. Basbaum and J.-M. Besson, pp. 181-203, John Wiley & Sons, Ltd., New York, 1991.
136. FOLKARD, S., GLYNN, C. J., AND LLOYD, J. W.: Diurnal variation and individual differences in the perception of intractable pain. J. Psychosom. Res. 20: 289-301, 1976.
137. FRASER, H. F., ISBELL, H., AND VAN HORN, G. D.: Effects of morphine as compared with a mixture of morphine and diaminophenylthiazole (daptazole). Anesthesiology 18: 531-535, 1957.
138. FREDERICKSON, R. C. A., BURGIS, V., HARRELL, C. E., AND EDWARDS, J. D.: Dual actions of substance P on nociception: possible role of endogenous opioids. Science (Wash. DC) 199: 1359-1362, 1978.
139. FRY, J. P., ZIEGLGÄNSBERGER, W., AND HERZ, A.: Development of acute opioid tolerance and dependence in rat striatal neurones. Naunyn-Schmiedebergs Arch. Pharmakol. 313: 145-149, 1980.
140. FU, Q.-G., SANDKÜHLER, J., AND ZIMMERMANN, M.: B-vitamins enhance afferent inhibitory controls of nociceptive neurons in the rat spinal cord. Klin. Wochenschr. 68: 125-128, 1990.
141. GAMSE, R., HOLZER, P., AND LEMBECK, F.: Decrease of substance P in primary afferent neurones and impairment of neurogenic plasma extravasation by capsaicin. Br. J. Pharmacol. 68: 207-213, 1980.
142. GARCIA, J., KIMMELDORF, D. J., AND KOELING, R. A.: Conditioned aversion to saccharin resulting from exposure to gamma radiation. Science (Wash. DC) 122: 157-158, 1955.
143. GAUTRON, M., AND GUILBAUD, G.: Somatic responses of ventrobasal thalamic neurons in polyarthritic rats. Brain Res. 237: 459-471, 1982.
144. GEAR, R. W., AND LEVINE, J. D.: Antinociception produced by an ascending spino-supraspinal pathway. J. Neurosci. 15: 3154-3161, 1995.
145. GEDDES, I. C., AND GRAY, T. C.: Hyperventilation for the maintenance of anaesthesia. Lancet, ii: 4-6, 1959.
146. GELLERT, V. F., AND HOLTZMAN, S. G.: Development and maintenance of morphine tolerance and dependence in the rat by scheduled access to morphine drinking solutions. J. Pharmacol. Exp. Ther. 205: 536-549, 1978.
147. GELLERT, V. F., AND SPARBER, S. B.: A comparison of the effects of naloxone upon body weight loss and suppression of fixed-ratio operant behavior in morphine dependent rats. J. Pharmacol. Exp. Ther. 201: 44-54, 1977.
148. GEORGES, E., SHAROM, F. F., AND LING, V.: Multidrug resistance and chemosensitization: therapeutic implications for cancer chemotherapy. Adv. Pharmacol. Chemother. 21: 185-220, 1990.
149. GERLACH, J. H., KARTNER, N., BELL, D. R., AND LING, V.: Multidrug resistance. Cancer Surv. 5: 25-46, 1986.
150. GLAVINA, M. J., AND ROBERTSHAW, R.: Myoclonic spasms following intrathecal morphine. Anaesthesia 43: 389-390, 1988.
151. GLYNN, C. J., LLOYD, J. W., AND FOLKHARD, S.: Ventilatory response to intractable pain. Pain 11: 201-211, 1981.
152. GODEFROY, F., WEIL-FUGAZZA, J., AND BESSON, J.-M.: Complex temporal changes in 5-hydroxytryptamine synthesis in the central nervous system induced by experimental polyarthritis in the rat. Pain 28: 223-238, 1987.
153. GOLD, L. H., STINUS, L., INTURISSI, C. E., AND KOOB, G. F.: Prolonged tolerance, dependence and abstinence following subcutaneous morphine pellet implantation in the rat. Eur. J. Pharmacol. 253: 45-51, 1994.
154. GOLDFARB, J., KAPLAN, E. I., AND JENKINS, H. R.: Interaction of morphine and naloxone in acute spinal cats. Neuropharmacology 17: 569-575, 1978.
155. GOLDIE, J. H., PRICE, L. A., AND HARRAP, K. R.: Methotrexate toxicity: correlation with duration of administration, plasma levels, dose and excretion. Eur. J. Cancer 8: 409-414, 1972.
156. GOLDSTEIN, A., AND SHEEHAN, P.: Tolerance to opioid narcotics. I. Tolerance to the "running fit" caused by levorphanol in the mouse. J. Pharmacol. Exp. Ther. 169: 175-184, 1969.
157. GOUDIE, A. J.: Conditioned opponent processes in the development of tolerance to psychoactive drugs. Prog. Neuropsychopharmacol. Biol. Psychiatr. 14: 675-688, 1990.
158. GOUDIE, A. J., AND EMMETT-OGLESBY, M. W., EDS. Tolerance and Sensitization, Humana Press, Clifton, New York, 1989.
159. GOUDIE, A. J., THORNTON, E. W., AND WHEALLER, T. J.: Drug pretreatment effects in drug-induced taste aversions: effects of dose and duration of pretreatment. Pharmacol. Biochem. Behav. 4: 629-633, 1976.
160. GOURLAY, G. K.: Long term use of opioids in chronic pain patients with non terminal disease states. Pain Rev. 1: 62-76, 1994.
161. GRAY, T. C., AND REES, G. J.: The role of apnoea in anesthesia for major surgery. Br. Med. J. 47: 891-893, 1952.
162. GREEN, D. M., AND SWETS, J. A.: Signal Detection Theory and Psychophysics, Wiley, New York, 1966.
163. GROSSMAN, S. P.: A Textbook of Physiological Psychology, John Wiley & Sons, Inc., New York, 1967.
164. GUILBAUD, G., BENOIST, J. M., GAUTRON, M., AND KAYSER, V.: Aspirin clearly depresses responses of ventrobasal thalamus neurons to joint stimuli in arthritic rats. Pain 13: 153-163, 1982.
165. GUILBAUD, G., IGGO, A., AND TEGNER, R.: Sensory receptors in ankle joint capsules of normal and arthritic rats. Exp. Brain Res. 58: 29-40, 1985a.
166. GUILBAUD, G., IGGO, A., AND TEGNER, R.: Sensory changes in joint-capsule receptors of arthritic rats: effect of aspirin. In Advances in Pain Research and Therapy, ed. by H. L. Fields, vol. 9, pp. 81-89, Raven Press, New York, 1985b.
167. GUPTA, R. S.: Cross resistance of vinblastine- and taxol-resistant mutants of Chinese hamster ovary cells to other anticancer drugs. Cancer Treat. Rep. 69: 515-521, 1985.
168. GUTSTEIN, H. B., TRUJILLO, K. A., AND AKIL, H.: Does chronic nociceptive stimulation alter the development of morphine tolerance? Brain Res. 680: 173-179, 1995.
169. GYBELS, J., DOM, R., AND COSYNS, P.: Electrical stimulation of the central gray for pain relief in human: autopsy data. Acta Neurochir. 30(suppl.): S259-S268, 1980.
170. HAIGLER, H. J.: Neurophysiological effects of opiates in the CNS. Monogr. Neural Sci. 13: 132-160, 1987.
171. HAMMOND, D. L.: Do opiates relieve central pain? In Pain and Central Nervous System Disease: The Central Pain Syndromes, ed. by K. L. Casey, pp. 233-241, Raven Press, New York, 1991.
172. HANKS, G. W., TWYCROSS, R. G., AND LLOYD, J. W.: Unexpected complications of successful nerve block. Morphine-induced respiratory depression precipitated by removal of severe pain. Anaesthesia 36: 37-39, 1981.
173. HENRY, J. L.: Effects of substance P on functionally identified units in cat spinal cord. Brain Res. 114: 439-451, 1976.
174. HERLING, S., AND WOODS, J. H.: Discriminative stimulus effects of narcotics: evidence for multiple receptor-mediated actions. Life Sci. 28: 1571-1584, 1981.
175. HERZ, A., ED.: Opioids I., Springer-Verlag, New York, 1993.
176. HILL, B. T.: Biochemical and cell kinetic aspects of drug resistance. In Drug and Hormone Resistance in Neoplasia: Basic Concepts, ed. by L. Bruchovsky and J. H. Goldie, vol. 1, pp. 21-53, CRC Press, Boca Raton, FL, 1982.
177. HILL, B. T.: In vitro human tumour model systems for investigating drug resistance. Cancer Surv. 5: 129-149, 1986.
178. HILL, R. G.: Pharmacological considerations in the use of opioids in the management of pain associated with nonterminal disease states. Pain Rev. 1: 47-61, 1994.
179. HIROSE, K., AND JYOYAMA, H.: Measurement of arthritic pain and effects of analgesics in the adjuvant-treated rat. Jpn. J. Pharmacol. 21: 717-720, 1971.
180. HÖKFELT, T., KELLERTH, J. D., NILSSON, G., AND PERNOW, B.: Experimental immunohistochemical studies on the localization and distribution of substance P in cat primary sensory neurons. Brain Res. 100: 235-252, 1975.
181. HOLTZMAN, S. G.: Stimulus properties of opioids with mixed agonist and antagonist activity. Fed. Proc. 41: 2328-2332, 1982.
182. HOSKING, L. K., WHELAN, R. D. H., SHELLARD, S. A., DAVIES, S. L., HICKSON, M. K., AND HILL, B. T.: Multiple mechanisms of resistance in a series of human testicular teratoma cell lines selected for increasing resistance to etoposide. Int. J. Cancer 57: 259-267, 1994.
183. HOUDE, R. W.: Nathan B. Eddy Memorial Lecture: the analgesic connection. In Problems of Drug Dependence 1984, Proceedings of the 46th Annual Scientific Meeting, ed. by L. S. Harris, The Committee on Problems of Drug Dependence, Inc., NIDA Res. Monogr., 55: 4-13, 1985.
184. HOUDE, R. W., WALLENSTEIN, S. L., AND BEAVER, W. T.: Evaluation of analgesics in patients with cancer pain. In Clinical Pharmacology, International Encyclopedia of Pharmacology and Therapeutics, ed. by L. Lasagna, vol. 1, pp. 59-98, Pergamon, Oxford, 1966.
185. HUGHES, P., AND DRAGUNOW, M.: Induction of immediate-early genes and the control of neurotransmitter-regulated gene expression within the nervous system. Pharmacol. Rev. 47: 133-178, 1995.
186. HUNT, C. E.: The cardiorespiratory control hypothesis for sudden infant death syndrome. Clin. Perinatol. 19: 757-771, 1992.
187. HUNT, S. P., PINI, A., AND EVAN, Y.: Induction of C-fos-like protein in spinal cord neurons following sensory stimulation. Nature (Lond.) 328: 632-634, 1987.
188. HYLDEN, J. L. K., THOMAS, D. A., IARDOLA, M. J., NAHIR, R. L., AND DUBNER, R.: Spinal opioid analgesic effects are enhanced in a model of unilateral inflammation/hyperalgesia: possible involvement of noradrenergic mechanisms. Eur. J. Pharmacol. 194: 135-143, 1991.
189. 3H-nitrendipine binding. Prog. Clin. Biol. Res. 328: 469-472, 1990.
190. JACQUET, Y. F.: β-Endorphin and ACTH-opiate peptides with coordinated roles in the regulation of behavior. TINS 2: 140-143, 1979.
191. JADAD, A. R., CARROLL, D., GLYNN, C. J., MOORE, R. A., AND MCQUAY, H. J.: Morphine responsiveness of chronic pain: double-blind randomized crossover study with patient-controlled analgesia. Lancet 339: 1367-1371, 1992.
192. JAFFE, J. H.: Drug addiction and drug abuse. In Goodman and Gilman's The
193. JAFFE, J. H., AND MARTIN, W. R.: Opioid agonists and antagonists. In Goodman and Gillman's The Pharmacological Basis of Therapeutics, ed. by A. G. Gillman, T. W. Rall, A. L. Nies, and P. Taylor, P., vol. 9, pp. 485-593, MacMillan, New York, 1990.
194. JANSSEN, P. A. J., NIEMEGEERS, C. J. E., AND DONY, J. G. H.: The inhibitory effect of fentanyl (R 4263) and other morphine-like analgesics on the warm water induced tail withdrawal reflex in rats. Arzneim. Forsch. 13: 502-507, 1963.
195. JANSSEN, P. A. J., NIEMEGEERS, C. J. E., SCHELLEKENS, K. H. L., MARSBOOM, R. H. M. HERIN, V. V., AMERY, W. K. P., ADMIRAAL, P. V., BOSKER, J. T., CRUL, J. F., PEARCE C., AND ZEGVELD, C.: Bezitramide (R4845), a new potent and orally long-acting analgesic compound. Arzneim. Forsch. 21: 862-867, 1971.
196. JASINSKI, D. R.: Assessment of the abuse potentiality of morphine-like drugs (methods used in man). In Drug Addiction I., ed. by W. R. Martin, pp. 197-258, Springer-Verlag, New York, 1977.
197. JOHNSON, S. M., AND DUGGAN, A. W.: Dependence in the absence of tolerance to morphine. Eur. J. Pharmacol. 97: 305-308, 1984.
198. JOHNSON, S. M., AND FLEMING, W. W.: Mechanisms of cellular adaptive sensitivity changes: applications to opioid tolerance and dependence. Pharmacol. Rev. 41: 435-488, 1989.
199. JONES, R. S., AND WARD, J. R.: Studies on adjuvant-induced polyarthritis in rats. II. Histogenesis of joint and visceral lesions. Arthritis Rheum. 6: 23-35, 1963.
200. JONES, R. S., AND WARD, J. R.: Adjuvant induced polyarthritis in rats. Methods Achiev. Exp. Pathol. 1: 607-638, 1966.
201. JORIS, J., COSTELLO, A., DUBNER, R., AND HARGREAVES, K. M.: Opiates suppress carrageenan-induced edema and hyperthermia at doses that inhibit hyperalgesia. Pain 43: 95-103, 1990.
202. KAIKO, R. F., WALLENSTEIN, S. L., ROGERS, A. G., GRABINSKI, P. Y., AND HOUDE, R. W.: Analgesic and mood effects of heroin and morphine in cancer patients with postoperative pain. N. Engl. J. Med. 304: 1501-1505, 1981.
203. KALANT, H.: Nathan B. Eddy Memorial Award Lecture: tolerance and its significance for drug and alcohol dependence. In Problems of Drug Dependence 1986, Proceedings of the 48th Annual Scientific Meeting, ed. by L. S. Harris, The Committee on Problems of Drug Dependence, Inc., NIDA Res. Monogr., 76: 9-19, 1987.
204. KANDALL, S. R., ALBIN, R. S., GARTNER, L. M., LEE, K. S., EIDELMAN, A., AND LOWINSON, J.: The narcotic dependent mother: fetal and neonatal consequences. Early Human Dev. 1: 159-169, 1977.
205. KANETO, H., KOIDA, M., NAKANISHI, H., AND SASANO, H.: A scoring system for abstinence syndrome in morphine dependent mice and application to evaluate morphine type dependence liability of drugs. Jpn. J. Pharmacol. 23: 701-707, 1973.
206. KANETO, H., YAMAZAKI, A., AND KIHARA, T.: Evidence for dissociation of morphine analgesia, tolerance and dependence. J. Pharmacol. 37: 507-508, 1985.
207. KANTOR, T. G., CANTOR, R., AND TOM, E.: A study of hospitalized surgical patients on methadone maintenance. Drug Alcohol Depend. 6: 163-173, 1980.
208. KARTNER, N., SHALES, M., RIORDAN, J. R., AND LING, V.: Daunorubicin resistant Chinese hamster ovary cells expressing multidrug resistance and a cell-surface P-glycoprotein. Cancer Res. 43: 4413-4419, 1983.
209. KAYAN, S., AND MITCHELL, C. L.: The effects of chronic morphine administration on tooth pulp threshold in dogs and cats. Proc. Soc. Exp. Biol. (NY) 128: 755-790, 1968.
210. KAYAN, S., FERGUSON, R. K., AND MITCHELL, C. L.: An investigation of pharmacologic and behavioral tolerance to morphine in rats. J. Pharmacol. Exp. Ther. 185: 300-306, 1973.
211. KAYAN, S., WOODS, L. A., AND MITCHELL, C. L.: Morphine induced hyperalgesia in rats tested on the hot plate. J. Pharmacol. Exp. Ther. 177: 509-513, 1971.
212. KAYSER, V., BENOIST, J. M., AND GUILBAUD, G.: Further evidence for a strong depressive effect of low doses of morphine on VB thalamic neuronal responses (a study on arthritic rats). Brain Res. 267: 187-191, 1983.
213. KAYSER, V., BESSON, J.-M., AND GUILBAUD, G.: Paradoxical hyperalgesic effect of exceedingly low doses of systemic morphine in an animal model of persistent pain (Freund's adjuvant-induced arthritic rats). Brain Res. 414: 155-157, 1987.
214. KAYSER, V., BESSON, J.-M., AND GUILBAUD, G.: Effects of the analgesic agent tramadol in normal and arthritic rats: comparison with the effects of different opioids, including tolerance and cross-tolerance to morphine. Eur. J. Pharmacol. 195: 37-45, 1991.
215. KAYSER, V., FOURNIÉ-ZALUSKI, M. C., GUILBAUD, G., AND ROQUES, B. P.: Potent antinociceptive effects of kelatorphan (a highly efficient inhibitor of multiple enkephalin-degrading enzymes) systemically administered in normal and arthritic rats. Brain Res. 497: 94-101, 1989.
216. KAYSER, V., AND GUILBAUD, G.: Dose dependent analgesic and hyperalgesic effects of systemic naloxone in arthritic rats. Brain Res. 226: 344-348, 1981.
217. KAYSER, V., AND GUILBAUD, G.: The analgesic effects of various doses of morphine, but not those of the enkephalinase inhibitor thiorphan, are enhanced in arthritic rats. Brain Res. 267: 131-138, 1983.
218. KAYSER, V., AND GUILBAUD, G.: Further evidence for changes in the responsiveness of somatosensory neurons in arthritic rats: a study of the posterior intralaminar region of the thalamus. Brain Res. 323: 144-147, 1984.
219. KAYSER, V., AND GUILBAUD, G.: Can tolerance to morphine be induced in arthritic rats? Brain Res. 334: 335-338, 1985.
220. KAYSER, V., AND GUILBAUD, G.: Differential effects of various doses of morphine and naloxone on two nociceptive test thresholds in arthritic and normal rats. Pain 41: 353-363, 1990.
221. KAYSER, V., NEIL, A., AND GUILBAUD, G.: Repeated low doses of morphine induce a rapid tolerance in arthritic rats but a potentiation of opiate analgesia in normal animals. Brain Res. 383: 392-396, 1986.
222. KELEMEN, K.: Analgesia, tolerance and drug dependence. In Hormones and Brain Function, ed. by K. Lissak, pp. 273-283, Plenum Press, New York, 1973.
223. KIM, D. H., FIELDS, H. L., AND BARBARO, N. M.: Morphine analgesia and acute physical dependence: rapid onset of two opposing, dose-related processes. Brain Res. 516: 37-40, 1990.
224. KITAHATA, L. M., KOSAKA, Y., TAUB, A., BONIKOS, K., AND HOFFERT, M.: Lamina specific suppression of dorsal horn unit activity by morphine sulfate. Anesthesiology 41: 39-48, 1974.
225. KJAERSGAARD-ANDERSEN, P., NAFEI, A., SKOV, O., MODSEN, F., ANDERSEN, H. M., KRONER, K., HVASS, I., GJODERUM, O., PEDERSEN, L., AND BRANEBJERG, P. E.: Codeine plus paracetamol versus paracetamol in longer-term treatment of chronic pain due to osteoarthritis of the hip: a randomised double-blind, multi-centre study. Pain 43: 309-318, 1990.
226. KLAIN, D. B., KRAUSS, A. N., AND AULD, P. A. M.: Tachypnea and alkalosis in infante of narcotic-addicted mothers. N.Y. State J. Med. 1: 367-368, 1972.
227. KOLB, L., AND HIMMELSBACH, C. K.: Clinical studies of drug addiction. Am. J. Psychiatry 94: 759-799, 1938.
228. KOOB, G. F., AND BLOOM, F. E.: Cellular and molecular mechanisms of drug dependence. Science (Wash. DC) 242: 715-723, 1988.
229. KORF, J., BUNNEY, B. S., AND AGHAJANIAN, G. K.: Noradrenergic neurons: morphine inhibition of spontaneous activity. Eur. J. Pharmacol. 25: 165-169, 1974.
230. KORNETSKY, C.: Early studies of tolerance to morphine. In Problems of Drug Dependence, Proceeding of the 48th Annual Scientific Meeting, ed. by L. S. Harris, The Committee on Problems of Drug Dependence, Inc., NIDA Res. Monogr., 76: 20-28, 1987.
231. KOSERSKY, D. S., HARRIS, R. A., AND HARRIS, L. S.: Naloxone jumping activity in mice following the acute administration of morphine. Eur. J. Pharmacol. 21: 122-126, 1974.
232. KREEK, M. J.: Tolerance and dependence: implications for the pharmacological treatment of addiction. In Problems of Drug Dependence, Proceedings of the 48th Annual Scientific Meeting, ed. by L. S. Harris, The Committee on Problems of Drug Dependence, Inc., NIDA Res. Monogr., 76: 53-62, 1987.
233. KUPERS, R. C., AND GYBELS, J.: The consumption of fentanyl is increased in rats with nociceptive but not with neuropathic pain. Pain 60: 137-141, 1995.
234. KUPERS, R. C., KONINGS, H., ADRIAENSEN, H., AND GYBELS, J. M.: Morphine differentially affects the sensory and affective pain ratings in neurogenic and idiopathic forms of pain. Pain 47: 5-12, 1991.
235. KUPERS, R. C., VOS, B. P. J., AND GYBELS, J.: Stimulation of the nucleus paraventricularis thalami suppresses scratching and biting behaviour of arthritic rats and exerts a powerful effect on tests for acute pain. Pain 32: 115-125, 1988.
236. KURAISHI, Y., NAGASAWA, T., HAYASHI, K., AND SATOH, M.: Scratching behavior induced by pruritogenic but not algesiogenic agents in mice. Eur. J. Pharmacol. 275: 229-233, 1995.
237. LAIRD, J. M. A., AND CERVERO, F.: A comparative study of the changes in receptive-field properties of multireceptive and nocireceptive rat dorsal horn neurons following noxious mechanical stimulation. J. Neurophysiol. 62: 854-863, 1989.
238. LAMOUR, Y., GUILBAUD, G., AND WILLER, J. C.: Altered properties and laminar distribution of neuronal responses to peripheral stimulation in the SMI cortex of the arthritic rat. Brain Res. 273: 183-187, 1983.
239. LARUE, F., COLLEAU, S. M., BRASSEUR, L., AND CLEELAND, C. S.: Multicentre study of cancer pain and its treatment in France. Br. Med. J. 310: 1034-1037, 1995.
240. LE BARS, D., CHITOUR, D., AND CLOT, A. M.: The encoding of thermal stimuli by diffuse noxious inhibitory controls (DNIC). Brain Res. 230: 394-399, 1981.
241. LE BARS, D., DICKENSON, A. H., AND BESSON, J.-M.: Diffuse noxious inhibitory controls (DNIC). I. Effects on dorsal horn convergent neurones in the rat. Pain 6: 283-304, 1979.
242. LE BARS, D., GUILBAUD, G., JURNA, I., AND BESSON, J.-M.: Differential effects of morphine on responses of dorsal horn lamina V type cells elicited by A and C fibre stimulation in the spinal cat. Brain Res. 115: 518-524, 1976b.
243. LE BARS, D., MENETREY, D., BESSON, J.-M.: Effects of morphine upon the lamina V type cells activities in the dorsal horn of the decerebrate cat. Brain Res. 113: 293-310, 1976a.
244. LE BARS, D., VILLANUEVA, L., BOUHASSIRA, D., AND WILLER, J.-C.: Diffuse noxious inhibitory controls (DNIC) in animals and in man. Pathol. Physiol. Exp. Ther. 4: 55-65, 1992.
245. LEHMANN, K. A., AND ZECH, D.: Transdermal fentanyl: clinical pharmacology. J. Pain Sympt. Manag. 7(suppl.): S8-S16, 1992.
246. LEMBECK, F., DONNERER, J., AND COLPAERT, F. C.: Increase of substance P in primary afferent nerves during chronic pain. Neuropeptides 1: 175-180, 1981.
247. LEMBECK, F., AND ZETLER, G.: Substance P: a polypeptide of possible physiological significance, especially within the nervous system. Int. Rev. Neurobiol. 4: 159-215, 1962.
248. LÉRIDA, M., SANCHEZ-BLAZQUEZ, P., AND GARZON, J.: Incidence of morphine withdrawal and quasi-abstinence syndrome in a model of chronic pain in the rat. Neurosci. Lett. 81: 155-158, 1987.
249. LEVINE, J. D., FIELDS, H. L., AND BASBAUM, A. I.: Peptides and the primary afferent nociceptor. J. Neurosci. 13: 2273-2286, 1993.
250. LIGHT, A. B., TORRANCE, E. G., KARR, W. G., FRY, E. G., AND WOLFF, W. A.: Opium Addiction (reprinted from Arch. Intern. Med. 43-44: 1929-1930), American Medical Association, Chicago, 1930.
251. LING, G. S. F., PAUL, D., SIMANTOV, R., AND PASTERNAK, G. W.: Differential development of acute tolerance to analgesia, respiratory depression, gastrointestinal transit and hormone release in a morphine infusion model. Life Sci. 45: 1627-1636, 1989.
252. LIPMAN, J. J., BLUMENKOPF, B., AND PARRIS, W. C.: Chronic pain assessment using heat beam dolometry. Pain 30: 59-67, 1987.
253. LIU, X.-G., AND SANDKÜHLER, J.: The effects of extrasynaptic substance P on nociceptive neurons in laminae I and II in rat lumbar spinal dorsal horn. Neuroscience 68: 1207-1218, 1995.
254. LOCKE, K. W., AND HOLTZMAN, S. G.: Behavioral effects of opioid peptides selective for mu or delta receptors. J. Pharmacol. Exp. Ther. 238: 997-1003, 1986.
255. LOH, K. H., AND SMITH, A. P.: Molecular characterization of opioid receptors. Annu. Rev. Pharmacol. Toxicol. 30: 123-147, 1990.
256. LOMBARD, M.-C., AND BESSON, J.-M.: Attempts to gauge the relative importance of pre- and postsynaptic effects of morphine on the transmission of noxious messages in the dorsal horn of the rat spinal cord. Pain 37: 335-345, 1989a.
257. LOMBARD, M.-C., AND BESSON, J.-M.: Electrophysiological evidence for a tonic activity of the spinal cord intrinsic opioid systems in a chronic pain model. Brain Res. 477: 48-56, 1989b.
258. LOTHSTEIN, L., AND HORWITZ, S. B.: Expression of phenotypic traits following modulation of colchicine resistance in J774.2 cells. J. Cell Physiol. 127: 253-260, 1986.
259. LYNESS, W. H., SMITH, F. L., HEAVNER, J. E., IACONO, C. U., AND GARVIN, R. D.: Morphine self-administration in the rat during adjuvant-induced arthritis. Life Sci. 45: 2217-2224, 1989.
260. MAN IN'T VELD, A. J., VAN DEN MEIRACKER, A. H., AND SCHALEKAMP, M. A.: Do beta-blockers really increase peripheral vascular resistance? Review of the literature and new observations under basal conditions. Am. J. Hypertens. 1: 91-96, 1988.
261. MAO, J., PRICE, D. D., AND MAYER, D. J.: Mechanisms of hyperalgesia and morphine tolerance: a current view of their possible interactions. Pain 62: 259-274, 1995.
262. MARKLEY, H. G.: Chronic headache: appropriate use of opiate analgesics. Neurology 44(suppl. 3): S18-S24, 1994.
263. MARTIN, W. R.: Drug Addiction I. & II., Springer, New York, 1977.
264. MARTIN, W. R.: Pharmacology of opioids. Pharmacol. Rev. 35: 283-323, 1984.
265. MARTIN, W. R., AND EADES, C. G.: A comparison between acute and chronic physical dependence in the chronic spinal dog. J. Pharmacol. Exp. Ther. 146: 385-394, 1964.
266. MARTIN, W. R., GILBERT, P. E., JASINSKI, P. E., AND MARTIN, C. D.: An analysis of naltrexone precipitated abstinence in morphine-dependent chronic spinal dogs. J. Pharmacol. Exp. Ther. 240: 565-570, 1987.
267. MARTIN, W. R., AND JASINSKI, D. R.: Physiological parameters of morphine dependence in man-tolerance, early abstinence, protracted abstinence. J. Psychiatr. Res. 7: 9-17, 1969.
268. MARTIN, W. R., MCNICHOLAS, L. F., AND CHERIAN, S.: Diazepam and pentobarbital dependence in the rat. Life Sci. 31: 721-730, 1982.
269. MARUTA, T., SWANSON, D. W., AND FINLAYSON, R. E.: Drug abuse and dependency in patients with chronic pain. Mayo Clin. Proc. 54: 241-244, 1979.
270. MCGIVNEY, W. T., AND CROOKS, G. M.: The care of patients with severe chronic pain in terminal illness. JAMA 251: 1182-1188, 1984.
271. MCLAUGHLIN, C. R., AND DEWEY, W. L.: A comparison of the antinociceptive effects of opioid agonists in neonatal and adult rats in phasic and tonic nociceptive tests. Pharmacol. Biochem. Behav. 49: 1017-1023, 1994.
272. MELZACK, R.: Humans versus pain: the dilemma of morphine. Adv. Pain Res. Ther. 20: 149-159, 1992.
273. MELZACK, R., AND WALL, P. D.: Pain mechanisms: a new theory. Science (Wash. DC) 150: 971-979, 1965.
274. MÉNARD, D. P., VAN ROSSUM, D., KAR, S., JOLICOEUR, F. B., JHAMANDAS, K., AND QUIRION, R.: Tolerance to the antinociceptive properties of morphine in the rat spinal cord: alteration of calcitocin gene-related peptide-like immune-staining and receptor binding sites. J. Pharmacol. Exp. Ther. 273: 887-894, 1995.
275. MENETREY, D., AND BESSON, J. M.: Electrophysiological characteristics of dorsal horn cells in rats with cutaneous inflammation resulting from chronic arthritis. Pain 13: 343-364, 1982.
276. MERCADANTE, S., MADDALONI, S., ROCELLA, S., AND SALVAGGIO, L.: Predictive factors in advanced cancer pain treated only by analgesics. Pain 50: 151-155, 1992.
277. MERSKEY, H.: The status of pain. In Modern Trends in Psychosomatic Medicine, ed. by O. W. Hill, vol. 3, pp. 166-186, Butterworth, London, 1976.
278. MERSKEY, H., AND BOGDUK, N., EDS.: Classification of Chronic Pain. IASP Press, Seattle, 1994.
279. MEYERSON, B. A.: Electrostimulation procedures: effects, presumed rationale, and possible mechanisms. In Advances in Pain Research and Therapy, ed. by J. J. Bonica, U. Lindblom, and A. Iggo, vol. 5, pp. 395-542, Raven Press, New York, 1983.
280. MILLAN, M. J., MILLAN, M. H., COLPAERT, F. C., AND HERZ, A.: Chronic arthritis in the rat: differential changes in discrete brain pools of vasopressin as compared to oxytocin. Neurosci. Lett. 54: 33-37, 1985a.
281. MILLAN, M. J., MILLAN, M. H., CZLONKOWSKI, A., HÖLLT, V., PILCHER, C. W. T., HEBZ, A., AND COLPAERT, F. C.: A model of chronic pain in the rat: responses of multiple opioid systems to adjuvant-induced arthritis. Neuroscience 6: 899-906, 1986a.
282. MILLAN, M. J., MILLAN, M. H., CZLONKOWSKI, A., PILCHER, C. W. T., HÖLLT, V., COLPAERT, F. C., AND HERZ, A.: Functional response of multiple opioid systems to chronic arthritic pain in the rat. N.Y. Acad. Sci. 467: 182-193, 1986b.
283. MILLAN, M. J., MILLAN, M. H., PILCHER, C. W. T., COLPAERT, F. C., AND HERZ, A.: Chronic pain in the rat: selective alterations in CNS and pituitary pools of dynorphin as compared to vasopressin. Neuropeptides 5: 423-424, 1985b.
284. MILLAN, M. J., MILLAN, M. H., PILCHER, C. W. T., CZLONKOWSKI, A., HERZ, A., AND COLPAERT, F. C.: Spinal cord dynorphin may modulate nociception via a κ-opioid receptor in chronic arthritis rats. Brain Res. 340: 156-159, 1985c.
285. MILLIGAN, G., BOND, R. A., AND LEE, M.: Inverse agonism: pharmacological curiosity or potential therapeutic strategy? TIPS 16: 10-13, 1995.
286. MOHIBUR-RAHMAN, A. F. M., TAKAHASHI, M., AND KANETO, H.: Development of tolerance to morphine antinociception in mice treated with nociceptive stimulants. Jpn. J. Pharmacol. 63: 59-64, 1993.
287. MOHRLAND, J. S., AND JOHNSON, E. E.: Use of the adjuvant-induced arthritic rat model to evaluate non-steroidal anti-inflammatory analgesics. J. Pharm. Pharmacol. 35: 401, 1983.
288. MORGAN, J. I., AND CURRAN, T.: Stimulus transcription coupling in the nervous system: involvement of the inducible proto-oncogenes fos and jun. Annu. Rev. Neurosci. 14: 421-451, 1991.
289. MORGAN, M. M., GOGAS, K. R., AND BASBAUM, A. I.: Diffuse noxious inhibitory controls reduce the expression of noxious stimulus-evoked Fos-like immunoreactivity in the superficial and deep laminae of the rat spinal cord. Pain 56: 347-352, 1994.
290. MORLEY, J. S., MILES, J. B., WELLS, J. C., AND BOWSHER, D.: Paradoxical pain. Lancet 340: 1045, 1992.
291. MORTOLA, J. P.: Dynamics of breathing in newborn mammals. Physiol. Rev. 67: 187-243, 1987.
292. MORTON, C. R., MAISCH, B., AND ZIMMERMANN, M.: Diffuse noxious inhibitory controls of lumbar spinal neurons involve a supraspinal loop in the cat. Brain Res. 410: 347-352, 1987.
293. MOUNT, B. M., AJEMIAN, I., AND SCOTT, J. F.: Use of the Brompton mixture in treating the chronic pain of malignant disease. CMAJ 115: 122-124, 1976.
294. MUELLER, R. A., LUNDBERG, D. B. A., BREESE, G. R., HEDNER, J., HEDNER, T., AND JONASON, J.: The neuropharmacology of respiratory control. Pharmacol. Rev. 34: 255-285, 1982.
295. MULÉ, S. J., CLEMENTS, T. H., LAYSON, R. C., AND HAERTZEN, C. A.: Analgesia in guinea pigs: a measure of tolerance development. Arch. Int. Pharmacodyn. 173: 201-212, 1968.
296. MULLER, H., STOYANOV, M, BORNER, U., AND HEMPELMANN, G.: Epidural opiates for relief of cancer pain. In Spinal Opiate Analgesia, ed. by T. L. Yaksh, H. Muller, and A. Engquist, pp. 125-137, Springer, Berlin, 1982.
297. NEIL, A. V., KAYSER, G., GACEL, G., BESSON, J.-M., AND GUILBAUD, G.: Opioid receptor types and antinociceptive activity in chronic inflammation: both κ-and μ-opiate agonistic effects are enhanced in arthritic rats. Eur. J. Pharmacol. 130: 203-208, 1986.
298. NESS, T. J., AND GEBHART, G. F.: Interactions between visceral and cutaneous nociception in the rat. I. Noxious cutaneous stimuli inhibit visceral nociceptive neurons and reflexes. J. Neurophysiol. 66: 20-28, 1991a.
299. NESS, T. J., AND GEBHART, G. F.: Interactions between visceral and cutaneous nociception in the rat. II. Noxious visceral stimuli inhibit cutaneous nociceptive neurons and reflexes. J. Neurophysiol. 66: 29-39, 1991b.
300. NESTLER, E. J.: Molecular mechanisms of drug addiction. J. Neurosci. 12: 2439-2450, 1992.
301. NIES, A. S.: Principles of therapeutics. In The Pharmacological Basis of Therapeutics, ed. by A. G. Gilman, T. W. Rall, A. S. Nies, and P. Taylor, pp. 62-83, Pergamon Press, New York, 1990.
302. 3H-nitrendipine binding to synaptic membranes: similarity with morphine tolerance. Naunyn-Schmiedebergs Arch. Pharmakol. 341: 123-127, 1990.
303. OKUYAMA, S., AND AIHARA, H.: Inhibition of electrically-induced vocalization in adjuvant-arthritic rats as a novel method for evaluating analgesic drugs. Jpn. J. Pharmacol. 34: 67-77, 1984a.
304. OKUYAMA, S., AND AIHARA, H.: Effects of morphine and indomethacin on evoked neuronal reponses of ventrobasal thalamic neurones: site of action of analgesic drugs in adjuvant arthritic rats. Jpn. J. Pharmacol. 36: 177-186, 1984b.
305. ONOFRIO, B. M., AND YAKSH, T. L.: Long term pain relief produced by intrathecal morphine infusion in 53 patients. J. Neurosurg. 72: 200-209, 1990.
306. OVERTON, D. A.: Experimental methods for the study of state-dependent learning. Fed. Proc. 33: 1800-1813, 1974.
307. OWEN, H., AND WHITE, P. F.: Patient controlled analgesia: an overview. In Acute Pain Mechanisms and Management, ed. by R. S. Sinatra, A. H. Hord, B. Ginsberg, and L. M. Preble, pp. 151-164, Mosby, Boston, 1992.
308. PAPPAGALLO, M., AND CAMPBELL, J. N.: Chronic opioid therapy as alternative treatment for post-herpetic neuralgia. Ann. Neurol. 35: S54-S56, 1994.
309. PARSONS, C. M., AND GOETZL, F. R.: Effects of induced pain on pain threshold. Proc. Soc. Exp. Biol. 60: 327-329, 1945.
310. PASTAN, I., AND GOTTESMAN, M. M.: Multidrug resistance. Annu. Rev. Med. 42: 277-286, 1991.
311. PASTERNAK, G. W.: Multiple morphine and enkephalin receptors and the relief of pain. JAMA 259: 1362-1367, 1988.
312. PASTERNAK, G. W.: Pharmacological mechanisms of opioid analgesics. Clin. Neuropharmacol. 16: 1-18, 1993.
313. PEARSON, C. M.: Development of arthritis, periarthritis and periostitis in rats given adjuvant. Proc. Soc. Exp. Biol. Med. (NY) 91: 95-101, 1956.
314. PEARSON, C. M.: Experimental joint disease: observations on adjuvant-induced arthritis. J. Chronic Dis. 16: 863-874, 1963.
315. PERNOW, B.: Substance P. Pharmacol. Rev.: 35: 85-141, 1983.
316. PICKER, M. J., AND YARBROUGH, J.: Cross tolerance and enhanced sensitivity to the response rate-decreasing effects of opioids with varying degress of efficacy at the mu receptor. Psychopharmacology 105: 459-466, 1991.
317. PIRCIO, A. W., FEDELE, C. T., AND BIERWAGEN, M. E.: A new method for the evaluation of analgesic activity using adjuvant-induced arthritis in the rat. Eur. J. Pharmacol. 31: 207-215, 1975.
318. POLLEN, J. J., AND SCHMIDT, J. D.: Bone pain in metastatic cancer of prostate. Urology 13: 129-134, 1979.
319. PORTENOY, R. K.: Chronic opioid therapy for persistent noncancer pain: can we get past the bias? Am. Pain Soc. Bull. 1: 1-5, 1991.
320. PORTENOY, R. K.: Opioid therapy for chronic nonmalignant pain: current status. In Progress in Pain Research and Management, ed. by H. L. Fields and J. C. Liebeskind, vol. 1, pp. 247-287, IASP Press, Seattle, 1994a.
321. PORTENOY, R. K.: Tolerance to opioid analgesics: clinical aspects. Cancer Surv. 21: 49-65, 1994b.
322. PORTENOY, R. K., AND FOLEY, K. M.: Chronic use of opioid analgesics in non-malignant pain: report of 38 cases. Pain 25: 171-186, 1986.
323. PORTENOY, R. K., FOLEY, K. M., AND INTURISSI, C. E.: The nature of opioid responsiveness and its implications for neuropathic pain: new hypotheses derived from studies of opioid infusions. Pain 43: 273-286, 1990.
324. POTTER, J. M., REID, D. B., SHAW, R. J., HACKETT, P., AND HICKMANN, P. E.: Myoclonus associated with treatment with high doses of morphine: the role of supplemental drugs. Br. Med. J. 299: 150-153, 1989.
325. PROCACCI, P., ZOPPI, M., AND MARESCA, M.: Experimental pain in man. Pain 6: 123-140, 1979.
326. RAINSFORD, K. D.: Adjuvant polyarthritis in rats: is this a satisfactory model for screening anti-arthritic drugs? Agents Actions 12: 452-458, 1982.
327. RALPHS, J. A., WILLIAMS, A. C. C., RICHARDSON, P. H., PITHER, C. E., AND NICHOLAS, M. K.: Opiate reduction in chronic pain patients: a comparison of patient-controlled reduction and staff controlled cocktail methods. Pain 56: 279-288, 1994.
328. RANDIC, M., AND MILETIC, V.: Depressant actions of methionine-enkephalin and somatostatin in cat dorsal horn neurones activated by noxious stimuli. Brain Res. 152: 196-202, 1978.
329. RATH, H., TISTY, T., AND SCHIMKE, R. T.: Rapid emergence of methotrexate resistance in cultured mouse cells. Cancer Res. 44: 3303-3306, 1984.
330. RAUHAIA, P., IDÄNPÄÄN-HEIKKILÄ, J. J., TUOMINEN, R. K., AND MÄNNISTÖ, P. T.: Differential disappearance of tolerance to thermal, hormonal and locomotor effects of morphine in the male rat. Eur. J. Pharmacol. 285: 69-77, 1995.
331. REDMOND, D. E., AND KRYSTAL, J. H.: Multiple mechanisms of withdrawal from opioid drugs. Annu. Rev. Neurosci. 7: 443-478, 1984.
332. REISINE, T.: Opiate receptors. Neuropharmacology 34: 463-472, 1995.
333. REULER, J. B., GIRARD, D. E., AND NARDONE, D. A.: The chronic pain syndrome: misconceptions and management. Ann. Intern. Med. 93: 588-596, 1980.
334. RIGATTO, H.: Maturation of breathing. Clin. Perinatol. 19: 739-756, 1992.
335. RITZMANN, R. F.: Opiate dependence following acute injections of morphine and naloxone: the assessment of various withdrawal signs. Pharmacol. Biochem. Behav. 14: 575-577, 1981.
336. ROBY-BRAMI, A., BUSSEL, B., WILLER, J. C., AND LE BARS, D.: An electrophysiological investigation into the pain-relieving effects of heterotopic nociceptive stimuli. Brain 110: 1497-1508, 1987.
337. RODGERS, R. J., AND RANDALL, J. I.: Environmentally induced analgesia: situational factors, mechanisms and significance. In Endorphins, Opiates and Behavioural Processes, ed. by R. J. Rodgers and S. J. Cooper, pp. 107-142, John Wiley, New York, 1988.
338. ROHDE, D. S., DETWEILER, D. J., AND BASBAUM, A. I.: Spinal cord mechanisms of opioid tolerance and dependence: fos-like immunoreactivity expression increases in subpopulations of spinal cord neurons during withdrawal. Neuroscience 72: 233-242, 1996.
339. ROSENTHALE, M. E., AND CAPETOLA, R. J.: Adjuvant arthritis: immunopathological and hyperalgesic features. Fed. Proc. 41: 2577-2582, 1982.
340. ROSOW, C.: Acute and chronic tolerance relevance for clinical practice. In Problems of Drug Dependence, Proceedings of the 48th Annual Scientific Meeting, ed. by L. S. Harris, L. S., The Committee on Problems of Drug Dependence, Inc., NIDA Res. Monogr., 76: 29-34, 1987.
341. ROSSBACH, M. J.: Ueber die Gewöhnung an Gifte. Arch. Gesmante Physiol. Mens. Tiere 21: 213-225, 1880.
342. RUBINSTEIN, R. B., SPIRA, I., AND WOLFF, W. I.: Management of surgical problems in patients on methadone maintenance. Am. J. Surg. 131: 566-569, 1976.
343. RUOFF, G. E.: Treatment of the chronic pain of osteoarthritis: zomepirac versus aspirin. Curr. Ther. Res. 32: 638-645, 1982.
344. RYAN, G. P., AND BOISSE N. R.: Experimental induction of benzodiazepine tolerance and physical dependence. J. Pharmacol. Exp. Ther. 226: 100-107, 1983.
345. SAGEN, J., AND WANG, H.: Adrenal medullary grafts suppress c-fos induction in spinal neurons of arthritic rats. Neurosci. Lett. 192: 181-184, 1995.
346. SALTER, M. W., AND HENRY, J. L.: Differential responses of nociceptive vs. non-nociceptive spinal dorsal horn neurones to cutaneously applied vibration in the cat. Pain 40: 311-322, 1990a.
347. SALTER, M. W., AND HENRY, J. L.: Physiological characteristics of responses of wide dynamic range spinal neurones to cutaneously applied vibration in the cat. Brain Res. 507: 69-84, 1990b.
348. SANDKÜHLER, J., AND EBLEN-ZAJJUR, A. A.: Identification and characterization of rhythmic nociceptive and non-nociceptive spinal dorsal horn neurons in the rat. Neuroscience 61: 991-1006, 1994.
349. SATOH, M., KAWAJIRI, S. I., UKAI, Y., AND YAMAMOTO, M.: Selective and non-selective inhibition by enkephalins and noradrenaline of nociceptive responses of lamina V type neurons in the spinal dorsal horn of the rabbit. Brain Res. 177: 384-387, 1979.
350. SAUNDERS, D. C.: Principles of symptom control in terminal care. Med. Clin. North Am. 66: 1169-1183, 1982.
351. SCHEPELMAN, K., MESSLINGER, K., SCHAIBLE, H.-G., AND SCHMIDT, R. F.: The opioid antagonist naloxone does not alter discharges of nociceptive afferents from the acutely inflamed knee joint of the cat. Neurosci. Lett. 187: 212-214, 1995.
352. SCHOENEN, J., VAN HEES, J., GYBELS, J., DE CASTRO-COSTA, C. M., AND VANDERHAEGHEN, J. J.: Histochemical changes of substance P, serotonin and succinic dehydrogenase in the spinal cord of rats with adjuvant arthritis. Life Sci. 36: 1247-1254, 1985.
353. SCHOENLEIN, P. V.: Molecular cytogenetics of multiple drug resistance. Cytotechnology 122: 63-89, 1993.
354. SHANNON, H. E., AND HOLTZMAN, S. G.: Evaluation of the discriminative effects of morphine in the rat. J. Pharmacol. Exp. Ther. 198: 54-65, 1976.
355. SHARMA, S. K., NIRENBERG, M., AND KLEE, W. A.: Morphine receptors as regulators of adenylate cyclase activity. Proc. Natl. Acad. Sci. USA 72: 590-594, 1975.
356. SHERMAN, J. E., PROCTOR, C., AND STRUB, H.: Prior hot plate exposure enhances morphine analgesia in tolerant and drug-naive rats. Pharmacol. Biochem. Behav. 17: 229-232, 1982.
357. SHERRINGTON, C. S.: The Integrative Action of the Central Nervous System, Constable, London, 1906.
358. SHIPPENBERG, T. S., STEIN, C., HUBER, C., MILLAN, M. J., AND HERZ, A.: Motivational effects of opioids in an animal model of prolonged inflammatory pain: alteration in the effects of kappa - but not of mu - receptor agonists. Pain 35: 179-186, 1988.
359. SIEGEL, S.: Pharmacological conditioning and drug effects. In Psychoactive Drugs: Tolerance and Sensitization, ed. by A. J. Goudie and M. W. Emmett-Oglesby, pp. 115-180, Humana Press, Clifton, NY, 1989.
360. SIEGEL, S.: Classical conditioning and opiate tolerance and withdrawal. In Psychotropic Drugs of Abuse, ed. by D. K. J. Balfour, pp. 59-85, Pergamon, New York, 1990.
361. SIGURDSSON, A., AND MAIXNER, W.: Effects of experimental and clinical noxious irritants on pain perception. Pain 57: 265-275, 1994.
362. SJOGREN, P., AND ERIKSEN, J.: Opioid toxicity. Curr. Opin. Anaesthesiol. 7: 465-469, 1994.
363. SJOGREN, P., JONSSON, T., JENSEN, N.-H., DRENCK, N.-E., AND JENSEN, T. S.: Hyperalgesia and myoclonus in terminal cancer patients treated with continuous intravenous morphine. Pain 55: 93-97, 1993.
364. SKINNER, B. F.: The Behavior of Organisms, Appleton-Century-Crofts, Inc., New York, 1938.
365. SKOVSGAARD, T., NIELSEN, D., MAARE, A., AND WASSERMANN, K.: Cellular resistance to cancer chemotherapy. Int. Rev. Cytol. 156: 77-157, 1994.
366. SMITH, A. P., LAW, P.-Y., AND LOH, H. H.: Role of opioid receptors in narcotic tolerance/dependence. In The Opiate Receptors, ed. by G. W. Pasternak, pp. 441-489, Humana Press, Totowa, NY, 1988.
367. SOFIA, R. D., AND VASSAR, H. B.: Changes in serotonin (5-HT) concentrations in brain tissue of rats with adjuvant-induced polyarthritis. Arch. Int. Pharmacodyn. 211: 74-79, 1974.
368. STANFA, L., DICKINSON, A., XU, X.-J., AND WIESENFELD-HALLIN, Z.: Cholecystokinin and morphine analgesia. TIPS 15: 65-66, 1994.
369. STEIN, C.: Peripheral mechanisms of opioid analgesia. Anesth. Analg. 76: 182-191, 1993.
370. STEIN, C., MILLAN, M. J., YASSOURDIS, A., AND HERZ, A.: Antinociceptive effects of μ- and κ-agonists in inflammation are enhanced by a peripheral opioid receptor-specific mechanism. Eur. J. Pharmacol. 155: 255-264, 1988a.
371. STEIN, C., MILLAN, M. J., SHIPPENBERG, T. S., AND HESZ, A.: Peripheral effects of fentanyl upon nociception in inflamed tissue of the rat. Neurosci. Lett. 84: 225-228, 1988b.
372. STERNBACH, R. A.: Pain: a psychophysiological analysis. Academic Press, New York, 1968.
373. STERNBACH, R. A.: Acute versus chronic pain. In Textbook of Pain, ed. by P. D. Wall and R. Melzack, pp. 173-177, Churchill Livingstone, New York, 1984.
374. STEVENS, C. W., AND YAHSH, T. L.: Potency of infused spinal antinociceptive agents is inversely related to magnitude of tolerance after continuous infusion. J. Pharmacol. Exp. Ther. 250: 1-8, 1989.
375. STRIAN, F., LAUTENBACHER, S., GALFE, G., AND HÖLZL, R.: Diurnal variations in pain perception and thermal sensitivity. Pain 36: 125-131, 1989.
376. SUFKA, K.: Conditioned place preference paradigm: a novel approach for analgesic drug assessment against chronic pain. Pain 58: 355-366, 1994.
377. SWETS, J. A.: Signal Detection and Recognition by Human Observers, Wiley, New York, 1964.
378. SWINGLE, K. F.: Evaluation of antiinflammatory activity. In Antiinflammatory Agents, ed. by R. A. Scherrer and M. W. Whitchouse, vol. 2, pp. 33-122, Academic Press, New York, 1974.
379. TAKEMORI, A. E.: Neurochemical basis for narcotic tolerance and dependence. Biochem. Pharmacol. 24: 2121-2126, 1975.
380. TALBOT, J. D., DUNCAN, G. H., AND BUSHNELL, M. C.: Effects of diffuse noxious inhibitory controls (DNICs) on the sensory-discriminative dimension of pain perception. Pain 36: 231-238, 1989.
381. TAUB, A.: Opioid analgesics in the treatment of chronic intractable pain of non-neoplastic origin. In Narcotic Analgesics in Anesthesiology, ed. by L. M. Kitahata and D. Collins, pp. 199-208, Williams & Wilkins, Baltimore, 1982.
382. TESKEY, G. C., AND KAVALIERS, M.: Modifications of social conflict-induced analgesic and activity responses in male mice receiving chronic opioid agonist and antagonist treatments. Pharmacol. Biochem. Behav. 38: 485-493, 1991.
383. THALER, H. T., FRIEDLANDER-KLAR, H., CIRRINCIONE, C.: A statistical approach to measuring analgesic response, In Proceedings of the VIth World Congress on Pain, ed. by M. R. Bond, J. E. Charlton, and C. J. Woolf, pp. 543-546, Elsevier, Amsterdam, 1991.
384. THERIAULT, E., OTSUKA, M., AND JESSEL, T.: Capsaisin evoked release of substance P from primary sensory neurons. Brain Res. 170: 209-213, 1979.
385. THUREL, C., BARDIN, T., AND BOCCARD, E.: Analgesic efficacy of an association of 500 mg paracetamol plus 30 mg codeine versus 400 mg paracetamol plus 30 mg dextropropoxyphene in repeated doses for chronic lower back pain. Curr. Ther. Res. 50: 463-473, 1991.
386. TILSON, H. A., RECH, R. H., AND STOLMAN, S.: Hyperalgesia during withdrawal as a means of measuring the degree of dependence in morphine dependent rats. Psychopharmacologia 28: 287-300, 1973.
387. TOLLE, T. R., CASRO-LOPES, J. M., COIMBRA, A., AND ZIEGLGÄNSBERGER, W.: Opiates modify induction of c-fos proto-oncogene in the spinal cord of the rat following noxious stimulation. Neurosci. Lett. 111: 46-51, 1990.
388. TOYOOKA, H., HANOAKA, K, OHTANI, M., YAMASHITA, M., TAUB, A., AND KITAHATA, L. M.: Suppressive effect of morphine on single-unit activity of cells in Rexed lamina VII. Anesthesiology 47: 513-517, 1977.
389. TRABER, J., GULLIS, R., AND HAMPRECHT, B.: Influence of opiates on the levels of adenosine 3′: 5′-cyclic monophosphate in neuroblastoma X glioma hybrid cells. Life Sci. 16: 1863-1868, 1975.
390. TRUJILLO, K. A., AND AKIL, H.: Opiate tolerance and dependence: recent findings and synthesis. New Biologist 3: 915-923, 1991.
391. TWYCROSS, R. G.: Clinical experience with diamorphine in advanced malignant disease. Int. J. Clin. Pharmacol. Ther. Toxicol. 9: 184-198, 1974.
392. TWYCROSS, R. G.: Relief of pain. In The Management of Terminal Disease, ed. by C. M. Saunders, pp. 65-98, Edward Arnold, Ltd., London, 1978.
393. TWYCROSS, R. G., AND MCQUAY, H. J.: Opioids. In The Textbook of Pain, ed. by P. D. Wall and R. Melzack, pp. 686-701, Churchill Livingstone, London, 1989.
394. TWYCROSS, R. G., AND WALD, S. J.: Longterm use of diamorphine in advanced cancer. In Advances in Pain Research and Therapy, ed. by J. J. Bonica and D. G. Albe-Fessard, vol. 1, pp. 653-661, Raven Press, New York, 1976.
395. VACCARINO, A. L., MAREK, P., KEST, B., BEN-ELIYAHU, S., COURET, L. C., KAO, B., AND LIEBESKIND, J. C.: Morphine fails to produce tolerance when administered in the presence of formalin pain in rats. Brain Res. 627: 287-290, 1993.
396. VAN BEVER, W., AND LAL, H. (EDS.) Synthetic Antidiarrheal Drugs, Marcel Dekker, Inc., New York, 1976.
397. VAN DEN HOOGEN, R. H. W. M., BERVOETS, K. J. W., AND COLPAERT, F. C.: Respiratory effects of epidural morphine and sufentanil in the absence and presence of chlordiazepoxide. Pain 37: 103-110, 1989.
398. VAN DEN HOOGEN, R. H. W. M., AND COLPAERT, F. C.: Respiratory effects of morphine in awake unrestrained rats. J. Pharmacol. Exp. Ther. 237: 252-259, 1986.
399. VICKERS, D.: Decision processes in visual perception. Academic Press, New York, 1979.
400. VIERCK, C. J., AND COOPER, B. Y.: Guidelines for assessing pain reactions and pain modulation in laboratory animal subjects. In Advances in Pain Research and Therapy, ed. by L. Kruger and J. C. Liebeskind, vol. 6, pp. 305-322, Raven Press, New York, 1984.
401. VLOK, G. J., AND VAN VUREN, J. P.: Comparison off a standard ibuprofen treatment regimen with a new ibuprofen/paracetamol/codeine combination in chronic osteoarthritis. S. Afr. Med. J. 1(suppl.): 4-6, 1987.
402. VOLM, M., BAK, M., JR., EFFERTH, T., AND MATTERN, J.: Induced multidrug-resistance in murine sarcoma 180 cells grown in vitro and in vivo and associated changes in expression of multidrug-resistance DNA-sequences and membrane glycoproteins. Anticancer Res. 8: 1169-1178, 1988.
403. WALLENSTEIN, S. L., HOUDE, R. W., PORTENOY, R. K., LAPIN, J., ROGERS, A., AND FOLEY, K. M.: Clinical analgesic assay of repeated and single doses of heroin and hydromorphone. Pain 41: 5-13, 1990.
404. WALSH, T. O.: Oral morphine in chronic cancer pain. Pain 18: 1-11, 1984.
405. WAND-TETLEY, J. I.: Historical methods of counter-irritation. Ann. Phys. Med. 3: 90-98, 1956.
406. WANG, H., AND SAGEN, J.: Attenuation of pain-related hyperventilation in adjuvant arthritic rats with adrenal medullary transplants in the spinal subarachnoid space. Pain 63: 313-320, 1995.
407. WARD, J. R., AND JONES, R. S.: Studies on adjuvant-induced polyarthritis in rats. I. Adjuvant composition, route of injection and removal of depot site. Arthritis Rheum. 5: 557-571, 1962.
408. WARNCKE, T., BREIVIK, H., AND VAINIO, A.: Treatment of cancer pain in Norway: a questionnaire study. Pain 57: 109-116, 1994.
409. WASCHULEWSKI, F. H., MILTNER, W., BRODY, S., AND BRAUN, C.: Classical conditioning in pain responses. Int. J. Neurosci. 78: 21-32, 1994.
410. WAY, E. L., LOH, H. H., AND SHEN, F.-H.: Simultaneous quantitative assessment of morphine tolerance and physical dependence. J. Pharmacol. Exp. Ther. 167: 1-8, 1969.
411. WEI, E., LOH, H. H., AND WAY, E. L.: Quantitative aspects of precipitated abstinence in morphine-dependent rats. J. Pharmacol. Exp. Ther. 184: 398-403, 1973.
412. WEIHE, E., IADORALA, M. J., NOHR, D., MÜLLER, S., MILLAN, M. J., YANAIHARA, N., STEIN, C., AND HERZ, A.: Sustained expression and colocalization of proenkephalin and prodynorphin opioids and C-fos protein in dorsal horn neurones revealed in arthritic rats. In New Leads in Opioid Research, ed. by J. van Ree, A. H. Mulder, V. M. Wiegant, and T. B. van Wimersma Greidanus, pp. 92-94, Elsevier, Amsterdam, 1990.
413. WEIL-FUGAZZA, J., GODEFROY, F., AND BESSON, J.-M.: Changes in brain and spinal tryptophan and 5-hydroxyindoleacetic acid levels following acute morphine administration in normal and arthritic rats. Brain Res. 175: 291-301, 1979.
414. WEIL-FUGAZZA, J., GODEFROY, F., BINEAU-THUROTTE, M., AND BESSON, J. M.: Plasma tryptophan levels and 5-hydroxytryptamine synthesis in the brain and the spinal cord in arthritic rats. In Progress in Tryptophan and Serotonin Research, ed. by H. G. Schlossberger, W. Kochen, B. Linzen, and H. Steinhart, pp. 405-408, Walter de Gruyter, Berlin, 1984.
415. WEIL-FUGAZZA, J., GODEFROY, F., COUDERT, D., AND BESSON, J.-M.: Total and free serum tryptophan levels and brain 5-hydroxytryptamine metabolism in arthritic rats. Pain 9: 319-325, 1980.
416. WEIL-FUGAZZA, J., GODEFROY, F., MANCEAU, V., AND BESSON, J.-M.: Increased norepinephrine and uric acid levels in the spinal cord of arthritic rats. Brain Res. 374: 190-194, 1986.
417. WHELAN, R. D. H., AND HILL, B. T.: Differential expression of steroid receptors, hsp27 and pS2 in a series of drug resistant human breast tumor cell lines derived following exposure to antitumor drugs or to fractionated X-irradiation. Breast Cancer Res. Treat. 26: 23-39, 1993.
418. WIKLER, A.: Dynamics of drug dependence. Arch. Gen. Psychiatry 28: 611-616, 1973.
419. WILCOX, R. E., MIKULA, J. A., AND LEVITT, R. A.: Periaqueductal gray naloxone microinjections in morphine-dependent rats: hyperalgesia without "classical" withdrawal. Neuropharmacology 18: 639-641, 1979.
420. WILLER, J. C., ROBY, A., AND LE BARS, D.: Psychophysical and electrophysiological approaches to the pain relieving effects of heterotopic nociceptive stimuli. Brain 107: 1095-1112, 1984.
421. WINTER, C. A., AND FLATAKER, L.: Reaction thresholds to pressure in edematous hindpaws of rats and responses to analgesic drugs. J. Pharmacol. Exp. Ther. 150: 65-171, 1965.
422. WINTER, C. A., KLING, P. J., TOCCO, D. J., AND TANABE, K.: Analgesic activity of diflunisal in rats with hyperalgesia induced by Freund's adjuvant. J. Pharmacol. Exp. Ther. 211: 678-725, 1979.
423. WOLFF, H. G., HARDY, J. D., AND GOODELL, H.: Studies on pain. Measurement of the effect of morphine, codeine, and other opiates on the pain threshold and an analysis of their relationship to the pain experience. J. Clin. Invest. 19: 659-680, 1940.
424. WOOLF, C. J., AND WALL, P. D.: Morphine sensitive and morphine-insensitive actions of C-fibre input on the rat spinal cord. Neurosci. Lett. 64: 221-225, 1986.
425. WÜSTER, M., SCHULZ, R., AND HERZ, A.: The development of opiate tolerance may dissociate from dependence. Life Sci. 31: 1695-1698, 1982.
426. YAKSH, T. L., AND NOUEIHED, R.: The physiology and pharmacology of spinal opiates. Annu. Rev. Pharmacol. Toxicol. 25: 433-462, 1985.
427. YAKSH, T. L., AND RUDY, T. A.: Studies on the direct spinal action of narcotics in the production of analgesia in the rat. J. Pharmacol. Exp. Ther. 202: 411-418, 1977.
428. YASHPAL, K., PITCHER, G. M., AND HENRY, J. L.: Noxious peripheral stimulation produces antinociception mediated via substance P and opioid mechanisms in the rat tail-flick test. Brain Res. 674: 97-103, 1995.
429. YOBURN, B. C., CHEN, J., HUANG, T., AND INTURRISI, C. E.: Pharmacokinetics and pharmacodynamics of subcutaneous morphine pellets in the rat. J. Pharmacol. Exp. Ther. 235: 282-286, 1985.
430. YONEHARA, N., KUDO, T., IWATSUBO, K., MAEDA, S., SAITO, K., AND INOKI, R.: A possible involvement of the central endorphin system in autoanalgesia induced by chronic administration of Freund's Adjuvant solution in rats. Pain 17: 91-98, 1983.
431. YOUNG, A. M.: Tolerance to drug stimulus control. Drug Dev. Res. 20: 205-215, 1990.
432. YOUNG, A. M.: Tolerance to drugs acting as discriminative stimuli. In Drug Discrimination: Applications to Drug Abuse Research, ed. by R. A. Glennon, T. U. C. Järbe, and J. Prankenheim, NIDA Res. Monogr. 116, pp. 197-212, U.S. Government Printing Office, Washington, D.C., 1991.
433. YOUNG, A. M., AND SANNERUD, C. A.: Tolerance to drug discriminative stimuli. In Tolerance and Sensitization, ed. by A. J. Goudie and M. W. Emmett-Oglesby, pp. 221-278, Humana Press, Clifton, NY, 1989.
434. ZENZ, M.: Morphine myths: sedation, tolerance, addiction. Postgrad. Med. J. 67(suppl): S100-S102, 1991.
435. ZENZ, M., SCHAPPLER-SCHEELE, B., NEUHAUS, R., PIEPENBROCK, S., AND HILFRICH, J.: Long term peridural analgesia in cancer pain [letter]. Lancet 1:91, 1981.
436. ZENZ, M., AND SORGE, J.: Is the therapeutic use of opioids adversely affected by prejudice and law? Recent Results Cancer Res. 121: 43-50, 1991.
437. ZENZ, M., STRUMPF, M., AND TRYBA, M.: Long-term opioid therapy in patients with chronic nonmalignant pain. J. Pain Symptom Manage. 7: 69-77, 1992.
438. ZENZ, M., STRUMPF, M., TRYBA, M., RÖHRS, E., AND STEFFMAN, B.: Retardiertes Morphin zur Langzeittherapie schwerer Tumorschmerzen. Dtsch. Med. Wochenschr. 114: 43-47, 1989.
439. ZENZ, M., AND WILLWEBER-STRUMPF, A.: Opiophobia and cancer pain in Europe. Lancet 341: 1075-1076, 1993.
440. ZIEGLGÄNSBERGER, W., AND BAYERL, H.: The mechanism of inhibition of neuronal activity by opiates in the spinal cord of the cat. Brain Res. 115: 111-128, 1976.
441. ZYLICZ, Z., AND TWYCROSS, R. G.: Oral opioids in the treatment of cancer pain. Neth. J. Med. 39: 108-114, 1991.